Skip to main content

GCM Grosvenor Inc.

For the period ended Dec 31, 2025. Filed Feb 19, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 19, 2026

GCMG$13.92+3.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Notes to Consolidated Financial Statements

  1. Organization

GCM Grosvenor Inc. (“GCMG”) and its subsidiaries including Grosvenor Capital Management Holdings, LLLP (the “Partnership” or “GCMH” and collectively, the “Company”), provide comprehensive investment solutions to institutional and individual clients who seek allocations to alternative investments such as absolute return strategies, private equity, real estate, infrastructure and alternative credit. The Company collaborates with its clients to construct investment portfolios across one or more investment strategies in the private and public markets, often customized to meet their specific objectives. The Company also offers specialized funds which span the alternatives investing universe and are developed to meet broad market demands for strategies and risk-return objectives.

The Company, through its subsidiaries acts as the investment adviser, general partner or managing member to customized funds and specialized funds (collectively, the “GCM Funds”).

GCMG was incorporated on July 27, 2020 under the laws of the State of Delaware for the purpose of consummating the Transaction as described below and merging with CF Finance Acquisition Corp. (“CFAC”), which was incorporated on July 9, 2014 under the laws of the State of Delaware. GCMG owns all of the equity interests of GCM Grosvenor Holdings, LLC (“IntermediateCo”), formerly known as CF Finance Intermediate Acquisition, LLC until November 18, 2020, which is the general partner of GCMH subsequent to the Transaction. GCMG’s ownership (through IntermediateCo) of GCMH as of December 31, 2025 and December 31, 2024 was approximately 30.0% and 23.7%, respectively.

GCMH is a holding company operated pursuant to the Fifth Amended and Restated Limited Liability Limited Partnership Agreement (the “Partnership Agreement”) dated November 17, 2020, among the limited partners including, Grosvenor Holdings, L.L.C. (“Holdings”), Grosvenor Holdings II, L.L.C. (“Holdings II”) and GCM Grosvenor Management, LLC (“Management LLC”) (collectively, together with GCM Progress Subsidiary LLC, the “GCMH Equityholders”).

On November 17, 2020, the Company consummated a business combination pursuant to the definitive Transaction Agreement dated as of August 2, 2020, by and among CFAC, IntermediateCo, CF Finance Holdings, LLC (the “CF Sponsor”), Holdings, Management LLC, Holdings II, GCMH GP, L.L.C. (“GCMHGP LLC”), GCM V, LLC (“GCM V”) and the Company (the “Transaction”). The Transaction was treated as a transaction between entities under common control.

GCMG indirectly holds general partnership and limited partnership interests in GCMH. The structure of the Transaction is an "Up-C” structure with the owners of GCMH retaining their ownership in GCMH.

  1. Summary of Significant Accounting Policies

Basis of Presentation

The Consolidated Financial Statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The Consolidated Financial Statements include the accounts of the Company, its wholly-owned or majority-owned subsidiaries and entities in which the Company is deemed to have a direct or indirect controlling financial interest based on either a variable interest model or voting interest model. All intercompany balances and transactions have been eliminated in consolidation.

The portion of the consolidated subsidiaries not owned by GCMG and any related activity is eliminated through noncontrolling interests in the Consolidated Statements of Financial Condition and net income (loss) attributable to noncontrolling interests in the Consolidated Statements of Income (Loss).

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation

The Company first determines whether it has a variable interest in an entity. Fees paid to a decision maker or service provider are not deemed variable interests in an entity if (i) the fees are compensation for services provided and are commensurate with the level of effort required to provide those services; (ii) the service arrangement includes only terms, conditions, or amounts that are customarily present in arrangements for similar services negotiated at arm’s length; and (iii) the decision maker does not hold other interests in the entity that individually, or in the aggregate, would absorb more than an insignificant amount of the entity’s expected losses or receive more than an insignificant amount of the entity’s expected residual returns. The Company has evaluated its arrangements and determined that management fees, performance fees and carried interest are customary and commensurate with the services being performed and are not variable interests. For those entities in which it has a variable interest, the Company performs an analysis to determine whether the entity is a variable interest entity (“VIE”).

The assessment of whether the entity is a VIE requires an evaluation of qualitative factors and, where applicable, quantitative factors. These judgments include: (a) determining whether the equity investment at risk is sufficient to permit the entity to finance its activities without additional subordinated financial support, (b) evaluating whether the equity holders, as a group, can make decisions that have a significant effect on the economic performance of the entity, and (c) determining whether the equity investors have proportionate voting rights to their obligations to absorb losses or rights to receive returns from an entity. The granting of substantive kick-out rights is a key consideration in determining whether a limited partnership or similar entity is a VIE.

For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it is the primary beneficiary. The Company is determined to be the primary beneficiary if it holds a controlling financial interest which is defined as possessing (a) the power to direct the activities that most significantly impact the VIE’s economic performance and (b) the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. In evaluating whether the Company is the primary beneficiary, the Company evaluates its economic interests in the entity held directly and indirectly by the Company.

The Company determines whether it is the primary beneficiary of a VIE at the time it becomes involved with a VIE and reconsiders that conclusion continuously. At each reporting date, the Company assesses whether it is the primary beneficiary and will consolidate or deconsolidate accordingly. Refer to Note 9 for additional information on the Company’s VIEs.

Entities that do not qualify as VIEs are assessed for consolidation as voting interest entities. Under the voting interest entity model, the Company consolidates those entities it controls through a majority voting interest.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash and short-term, highly liquid money market funds with original maturities of three months or less. In circumstances when Federal Deposit Insurance Corporation insured limits are exceeded, the risk of default depends on the creditworthiness of the counterparties to each of these transactions. Interest earned on cash and cash equivalents of $5.0 million, $2.7 million and $2.0 million during the years ended December 31, 2025, 2024 and 2023, respectively, is recorded within other income (expense) in the Consolidated Statements of Income (Loss). As of December 31, 2025 and 2024, the Company held $21.1 million and $18.5 million, respectively, of foreign cash included within cash and cash equivalents in the Consolidated Statements of Financial Condition.

Foreign Currency

The Company consolidates certain subsidiaries that have a non-U.S. dollar functional currency. The assets and liabilities of these subsidiaries are translated at the exchange rate prevailing at the reporting date and income and expenses are translated at the average monthly rates of exchange with the resulting translation adjustment included in the Consolidated Statements of Financial Condition as a component of accumulated other comprehensive income (loss).

The Company earns fees denominated in several different foreign currencies. Corresponding transaction gains or losses are recognized in other income (expense) in the Consolidated Statements of Income (Loss).

Management Fees and Incentive Fees Receivables

Management fees and incentive fees receivables are equal to contractual amounts reduced for allowances, including expected credit losses, if applicable. The Company considers fees receivable to be fully collectible; accordingly, minimal allowance for credit losses has been established as of December 31, 2025 and 2024. The Company’s management fees and incentive fees receivables are predominantly with its investments funds, which have low risk of credit loss based on the Company’s historical experience. Historical experience may be adjusted for current conditions and forecasts, including the Company’s expectation of near-term realizations. Allowances are charged directly to general, administrative and other in the Consolidated Statements of Income (Loss).

Due from Related Parties

Due from related parties includes amounts receivable from the Company’s existing partners, employees, and nonconsolidated funds. Refer to Note 17 for further disclosure of transactions with related parties.

Fair Value Measurements

The Company categorizes its fair value measurements according to a three-level hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are defined as follows:

Level 1 – Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and

Level 3 – Inputs that are unobservable and require significant management judgment or estimation.

Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available under the circumstances.

The carrying amounts of cash and cash equivalents and fees receivable approximate fair value due to the immediate or short-term maturity of these financial instruments.

Investments

Investments primarily consist of investments in GCM Funds and other funds the Company does not control, but is deemed to exert significant influence, and are generally accounted for using the equity method of accounting. Under the equity method of accounting, the Company records its share of the underlying income or loss of such entities, which reflects the net asset value of such investments. Management believes the net asset value of the funds is representative of fair value. The resulting gains and losses are included as investment income in the Consolidated Statements of Income (Loss).

The Company’s equity method investments in the GCM Funds investing in private equity, real estate and infrastructure (“GCM PEREI Funds”), are valued based on the most recent available information, which typically has a delay of up to three months due to the timing of financial information received from the investments held by the GCM PEREI Funds. The Company records its share of capital contributions to and distributions from the GCM PEREI Funds within investments in the Consolidated Statements of Financial Condition during the three-month lag period. To the extent that management is aware of material events that affect the GCM PEREI Funds during the intervening period, the impact of the events would be disclosed in the notes to the Consolidated Financial Statements.

Certain subsidiaries which hold the general partner capital interest in the GCM Funds are not wholly owned, and as such, the portion of the Company’s investments owned by limited partners in those subsidiaries are reflected within noncontrolling interests in the Consolidated Statements of Financial Condition.

The Company holds an investment in an unconsolidated entity, which is accounted for using the equity method of accounting. The investment is recognized at cost, adjusted for the Company’s share of the entity’s net income or loss, less any distributions or dividends received by the Company and any impairment of the investment. The Company records its share of capital contributions to and distributions from its investment within investments in the Consolidated Statements of Financial Condition during the three-month lag period. The Company records its proportionate share of net income or loss from the investment as investment income on the Consolidated Statements of Income (Loss) on a one quarter lag. To the extent that management is aware of material events that affect its investment during the intervening period, the impact of the events would be disclosed in the notes to the Consolidated Financial Statements.

For certain other debt investments, the Company has elected the fair value option. Such election is irrevocable and is made at the investment level at initial recognition. The debt investments are not publicly traded and are a Level 3 fair value measurement. For investments carried at fair value, the Company records the increase or decrease in fair value as investment income in the Consolidated Statements of Income (Loss). See Note 5 for additional information regarding the Company’s other investments.

Premises and Equipment

Premises and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets ranging from three totwelve years. Leasehold improvements are amortized over the shorter of their estimated useful lives or lease terms. See Note 10 for additional information regarding the Company’s premises and equipment.

Leases

The Company’s leases primarily consist of operating lease agreements for office space in various countries around the world, including for its headquarters in Chicago, Illinois. The Company accounts for its right of use (“ROU”) assets and lease liabilities under Accounting Standards Codification (“ASC”) 842, Leases. ROU assets and lease liabilities are recorded on the Consolidated Statements of Financial Condition for all operating leases with initial terms exceeding one year. Lease ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s remaining minimum lease obligations. The Company made a permitted accounting policy election not to apply the ROU model to short-term leases, which are defined as leases with initial terms of one year or less.

The Company determines whether a contract contains a lease at inception. Lease ROU assets and lease liabilities are initially recognized on the lease commencement date based on the present value of the minimum lease payments over the lease term. When determining the lease term, the Company generally does not include options to renew as it is not reasonably certain at contract inception that the Company will exercise the option(s). As the implicit rate is not generally readily determinable, the Company uses its incremental borrowing rate to determine the present value of future minimum lease payments. Lease ROU assets may include initial direct costs incurred by the Company and are reduced by lease incentives. Operating lease expense is recognized on a straight-line basis over the lease term within general, administrative and other in the Consolidated Statements of Income (Loss).

Intangible Assets and Goodwill

Finite-lived intangible assets primarily consist of investment management contracts, customer relationships, technology and trade name. These assets were amortized on a straight-line basis over their respective useful lives, ranging from 2 to 12 years. Intangible assets are reviewed for impairment whenever events or changes in circumstances suggest that the asset’s carrying value may not be recoverable. An impairment loss, calculated as the difference between the estimated fair value and the carrying value of the asset, is recognized if the sum of the estimated undiscounted cash flows relating to the asset is less than the corresponding carrying value. The Company has not recognized any impairment in any of the periods presented. All intangible assets have been fully amortized as of December 31, 2025.

Goodwill is reviewed for impairment at least annually at the reporting unit level utilizing a qualitative or quantitative approach, and more frequently if circumstances indicate impairment may have occurred. The impairment testing for goodwill under the qualitative approach is based first on a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit is less than its respective carrying value. If it is determined that it is more likely than not that the reporting unit’s fair value is less than its carrying value or when the quantitative approach is used, the amount of impairment is calculated as the excess of the carrying value of the reporting unit over its fair value.

The Company performed an annual assessment of its goodwill on October 1, 2025 and 2024 and did not identify any impairment.

Public and Private Warrants

The Company evaluated the public and private warrants under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and concluded that they do not meet the criteria to be classified as equity (deficit) in the Consolidated Statements of Financial Condition. Specifically, the exercise of the public and private warrants may be settled in cash upon the occurrence of a tender offer or exchange that involves 50% or more of the Company’s Class A shareholders. Because such a tender offer may not result in a change in control and trigger cash settlement and the Company does not control the occurrence of such event, the Company concluded that the public warrants and private warrants do not meet the conditions to be classified as equity (deficit) in the Consolidated Statements of Financial Condition. Since the public and private warrants meet the definition of a derivative under ASC 815, the Company recorded these warrants as liabilities in the Consolidated Statements of Financial Condition at fair value upon the closing of the Transaction in accordance with ASC 820, Fair Value Measurement, with subsequent changes in their respective fair values recorded in the change in fair value of warrant liabilities in the Consolidated Statements of Income (Loss) at each reporting date. There are no public or private warrants outstanding as of December 31, 2025.

Noncontrolling Interests

Noncontrolling interests (“NCI”) reflect the portion of income or loss and the corresponding equity attributable to third-party equity holders in certain consolidated subsidiaries that are not wholly owned by the Company in the Consolidated Financial Statements. Noncontrolling interests is presented as a separate component of equity (deficit) in the Consolidated Statements of Financial Condition. Net income attributable to GCM Grosvenor Inc., as reported on the Consolidated Statements of Income (Loss), presents net income net of the portion attributable to holders of non-controlling interest. Partnership interest-based compensation is 100% allocated to noncontrolling interest. Profits and losses, other than partnership interest-based compensation, are allocated to noncontrolling interest in proportion to their relative ownership interests.

Revenue Recognition

Contracts which earn the Company management fees and incentive fees are evaluated under ASC 606, Revenue from Contracts with Customers, for the services further described below. Under ASC 606, the Company is required to (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when (or as) the Company satisfies its performance obligation.

The Company earns management fees from providing investment management services to specialized funds and customized separate account clients. Specialized funds are generally structured as partnerships having multiple investors. Separate account clients may be structured using an affiliate-managed entity or may involve an investment management agreement between the Company and a single client. Certain separate account clients may have the Company manage assets both with full discretion over investments decisions as well as without discretion over investment decisions and may also receive access to various other advisory services the firm may provide as part of a single customized service which the Company has determined is a single performance obligation. The Company determined that for specialized funds, the fund is generally considered to be the customer while the individual investor or limited partner is the customer with respect to customized separate accounts. The Company satisfies its performance obligations over time as the services are rendered and the customer simultaneously receives and consumes the benefits of the services as they are performed, using the same time-based measure of progress towards completion.

The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised services to the customer. The Company’s management fees attributable to the GCM Funds investing in public market investments consist primarily of fees based on the net asset value of the assets managed. Fees may be calculated on a monthly or quarterly basis as of each subscription date, either in advance or arrears. Investment management fees calculated on a monthly or quarterly basis are primarily based on the assets under management at the beginning or end of such monthly or quarterly period or on average net assets.

The Company’s management fees attributable to the GCM Funds investing in longer-term public market investments and private market investments are typically based on limited partner commitments to those funds during an initial commitment or investment period. Following the expiration or termination of such period, the fees generally become based on invested assets or based on invested capital and unfunded deal commitments less returned capital. Management fees are determined quarterly and are more commonly billed in advance based on the management fee rate applied to the management fee base at the end of the preceding quarterly period as defined in the respective contractual agreements.

Management fees are a form of variable consideration as the basis for the management fee fluctuates over the life of the contract, therefore, management fees are constrained and not recognized until it is probable that a significant reversal will not occur.

Certain GCM Fund agreements contain a management fee schedule that simulates the pattern of a fee based on invested capital that increases over the investment period and decreases over the life of the fund. In those circumstances, the Company satisfies its performance obligations over time as the services are rendered and records as revenue the amounts it is entitled to invoice for the applicable quarter for which services have been rendered.

Certain agreements contain a requirement to return management fees for commitments left unfunded at the termination of the GCM Fund’s life. As of December 31, 2025 and December 31, 2024, deferred revenue of $4.2 million and $3.7 million, respectively, relating to the portion of the fees collected that the Company views as probable of being returned based on the Company’s investing experience, was recorded within accrued expenses and other liabilities in the Consolidated Statements of Financial Condition.

Certain operating agreements limit the expenses a fund bears to a percentage of the market value of the assets managed. The Company is required to reimburse the customer for such exceeded amounts (which the Company may be entitled to recoup in subsequent periods if expenses are sufficiently below the limit). The Company records these amounts as adjustments to the transaction price, which are reflected within management fees in the Consolidated Statements of Income (Loss).

Fund Expense Reimbursement Revenue

The Company incurs certain costs, primarily related to accounting, client reporting, investment-decision making and treasury-related expenditures, for which it receives reimbursement from the GCM Funds in connection with its performance obligations to provide investment management services. The Company concluded it controls the services provided and resources used before they are transferred to the customer and therefore is a principal. Accordingly, the reimbursement for these costs incurred by the Company are presented on a gross basis within management fees and the related costs within general, administrative and other in the Consolidated Statements of Income (Loss) with any outstanding amounts recorded within due from related parties in the Consolidated Statements of Financial Condition. Expense reimbursements are generally recognized at a point in time, in the periods during which the related expenses are incurred and the reimbursements are contractually earned.

The Company may pay on behalf of and seek reimbursement from GCM Funds for certain professional fees and administrative or other fund expenses that the Company arranges for the GCM Funds. The Company concluded that the nature of its promise is to arrange for the services to be provided and it does not control the services provided by third parties before they are transferred to the customer. As a result, the Company is acting in the capacity of an agent to the GCM Funds and the reimbursement for these professional fees paid on behalf of the investment funds is presented on a net basis. Accordingly, outstanding amounts related to these disbursements are recorded within due from related parties in the Consolidated Statements of Financial Condition.

Incentive Fees

Incentive fees consists of performance based incentive fees in the form of performance fees and carried interest.

The Company may receive performance fees from certain GCM Funds investing in public market investments. Performance fees are typically a fixed percentage of investment gains, subject to loss carryforward provisions that require the recapture of any previous losses before any performance fees can be earned in the current period. Performance fees may or may not be subject to a hurdle or a preferred return, which requires that clients earn a specified minimum return before a performance fee can be assessed. With the exception of certain GCM Funds, these performance fees are determined based upon investment performance at the end of a specified measurement period, generally the end of the calendar year. Certain GCM Funds have performance measurement periods extending beyond one year.

Investment returns are highly susceptible to market factors, judgments and actions of third parties that are outside of the Company’s control. Accordingly, performance fees are considered variable consideration and are therefore constrained and not recognized as revenue until it is probable that a significant reversal will not occur. In the event that a client redeems from one of the GCM Funds prior to the end of a measurement period, any accrued performance fee is ordinarily due and payable by such redeeming client as of the redemption date.

Carried interest is a performance-based capital allocation from a fund’s limited partners earned by the Company in certain GCM Funds invested in longer-term public market investments and private market investments. Carried interest is typically calculated as a percentage of the profits calculated in accordance with the terms of fund agreements at rates that range between 2.5%-20% after returning invested capital, certain fees and a preferred return to the fund’s limited partners. Carried interest is ultimately realized when underlying investments distribute proceeds or are sold and therefore carried interest is highly susceptible to market factors, judgments and actions of third parties that are outside of the Company’s control. Accordingly, carried interest is considered variable consideration and is therefore constrained and not recognized as revenue until it is probable that a significant reversal will not occur when the uncertainty associated with the variable consideration is subsequently resolved.

Agreements generally include a clawback provision that, if triggered, would require the Company to return up to the cumulative amount of carried interest distributed, typically net of tax, upon liquidation of those funds, if the aggregate amount paid as carried interest exceeds the amount actually due based upon the aggregate performance of each fund. Accordingly, the amount of carried interest, typically net of tax, that the Company would be required to return if all remaining investments had no value as of the end of each reporting period is deferred at each reporting period. As of December 31, 2025 and December 31, 2024, deferred revenue relating to constrained realized carried interest of $5.9 million and $6.0 million respectively, was recorded within accrued expenses and other liabilities in the Consolidated Statements of Financial Condition.

Other Operating Income

Other operating income primarily consists of administrative fees from certain private investment vehicles for which the Company performs a full suite of administrative functions, but for which the Company does not manage or advise. The Company satisfies its performance obligations for administrative fees over time as the services are rendered and the customer simultaneously receives and consumes the benefits of the services as they are performed, using the same time-based measure of progress towards completion. Other operating income also includes placement fees earned where the Company raised capital for certain investment vehicles. These fees are recognized upon the successful placement and funding of the related securities.

Distribution Relationships

The Company has entered into a number of distribution relationships with financial services firms to assist it in developing and servicing its client base. These relationships are non-exclusive and generally enable the Company to have direct contact with major clients.

Management and incentive fee revenue in the Consolidated Statements of Income (Loss) is recorded on a gross basis. Expenses pursuant to the revenue sharing arrangements in connection with these distribution agreements of $4.8 million, $5.5 million and $5.5 million for the years ended December 31, 2025, 2024 and 2023, respectively, were recorded within general, administrative and other in the Consolidated Statements of Income (Loss).

Cash-based Employee Compensation and Benefits

The Company compensates its employees through the cash payment of both a fixed component (“base salary”) and a variable component (“bonus”). Base salary is recorded on an accrual basis over each employee’s period of service. Bonus compensation is determined by the Company’s management and is generally discretionary taking into consideration, among other things, the financial results of the Company, as well as the employee’s performance.

Cash-based Incentive Fee Related Compensation

Incentive fee compensation consists of discretionary compensation accrued and paid annually based on the Company’s share of incentive fee revenue.

Carried Interest Compensation

Certain employees and former employees are entitled to a portion of the carried interest realized from certain GCM Funds, which generally vest over a multi-year period and are payable upon a realization of the carried interest. Accordingly, carried interest resulting from a realization event gives rise to the incurrence of an obligation. Amounts payable under these arrangements are recorded within employee compensation and benefits in the Consolidated Statements of Income (Loss) when they become probable and reasonably estimable.

For certain GCM Funds, realized carried interest is subject to clawback. Although the Company defers the portion of realized carried interest not meeting the criteria for revenue recognition, accruing an expense for amounts due to employees and former employees is based upon when it becomes probable and reasonably estimable that carried interest has been earned and therefore a liability has been incurred. As a result, the recording of an accrual for amounts due to employees and former employees generally precedes the recognition of the related carried interest revenue. The Company withholds a portion of the amounts due to employees and former employees as a reserve against contingent repayments to the GCM Funds. As of December 31, 2025 and 2024, an accrual of $7.6 million and $10.6 million, respectively, relating to amounts withheld was recorded within accrued compensation and employee related obligations in the Consolidated Statements of Financial Condition.

Other Non-cash Compensation

The Company has established deferred compensation programs for certain employees and accrues deferred compensation expense ratably over the related vesting schedules, recognizing an increase or decrease in compensation expense based on the performance of certain GCM Funds. In addition, the Company has granted compensation awards to employees that represent investments that will be made in GCM Funds on behalf of the employees and were compensation for past services that were fully vested upon the award date. Compensation expense related to deferred compensation and other awards are included within employee compensation and benefits in the Consolidated Statements of Income (Loss).

Partnership Interest-based Compensation

Various individuals, including current and former employees of the Company (“Recipients”), have been awarded partnership interests in Holdings, Holdings II and Management LLC. These partnership interests either (a) grant the Recipients the right to certain cash distributions of profits from Holdings, Holdings II and Management LLC to the extent such distributions are authorized or (b) transfer equity ownership between certain existing employee members of the GCMH Equityholders.

A partnership interest award is accounted for based on its substance. A partnership interest award that is in substance a profit-sharing arrangement or performance bonus would generally not be within the scope of the stock-based compensation guidance and would be accounted for under the guidance for deferred compensation plans, similar to a cash bonus. However, if the arrangement has characteristics more akin to the risks and rewards of equity ownership, the arrangement would be accounted for under stock-based compensation guidance. Since payments or settlements of partnership interest awards are made by GCMH Equityholders, the Company records a non-cash profits interest compensation charge and an offsetting deemed contribution to equity (deficit).

The Company analyzes awards granted to Recipients at the time they are granted or modified. Awards that are in substance a profit-sharing arrangement in which rights to distributions of profits are based fully on the discretion of the managing member of Holdings, Holdings II and Management LLC, are recorded within employee compensation and benefits in the Consolidated Statements of Income (Loss) when Holdings, Holdings II or Management LLC makes distributions to the Recipients. Awards that are in substance stock-based compensation are recorded within employee compensation and benefits in the Consolidated Statements of Income (Loss) on a straight-line basis over the service period based on the grant date fair value of the equity awards. Profit-sharing arrangements that contain a stated target payment are recognized as partnership interest-based compensation expense equal to the present value of expected future payments on a straight-line basis over the service period. Any such expense previously recorded is reversed if the target amount is canceled or forfeited or if the required service period is not provided.

Equity-Based Compensation

The Company accounts for grants of equity-based awards, including restricted stock units (“RSUs”), at fair value as of the grant date. Each RSU represents the right to receive payment in the form ofone share of Class A common stock or an amount equal to the market value ofone share of Class A common stock. Holders of unvested RSUs do not have the right to vote with the underlying shares of Class A common stock, but are generally entitled to accrue dividend equivalents, which are generally paid in cash when such RSUs are delivered. The Company recognizes compensation expense attributable to these grants on a straight-line basis over the requisite service period, which is generally the vesting period. Expenses related to grants of equity-based awards arerecorded within employee compensation and benefits in the Consolidated Statements of Income (Loss) and within additional paid-in capital andnoncontrolling interests in GCMHin the Consolidated Statements of Financial Condition. The grant-date fair value of RSUs is determined by the closing stock price on the grant date. Awards the Company intends to settle in cash as of the balance sheet date are classified as liabilities within accrued compensation and employee related obligations in the Consolidated Statements of Financial Condition and are subsequently remeasured to the closing stock price as of each reporting date through either the payment date or the date that the Company no longer intends to settle in cash, with the changes in fair value recorded within employee compensation and benefits in the Consolidated Statements of Income (Loss). Forfeitures of equity-based awards are recognized as they occur. See Note 12 for additional information regarding the Company’s equity-based compensation.

Derivative Instruments

Derivative instruments enable the Company to manage its exposure to interest rate risk. The Company generally does not engage in derivative or hedging activities, except to hedge interest rate risk on floating rate debt, as described in Note 14.

Derivatives are recognized in the Consolidated Statements of Financial Condition at fair value.

In order to qualify for hedge accounting, a derivative must be considered highly effective at reducing the risk associated with the exposure being hedged. At inception, the Company documents all relationships between derivatives designated as hedging instruments and hedged items, the risk management objectives and strategies for undertaking various hedge transactions, the method of assessing hedge effectiveness, and, if applicable, why forecasted transactions are considered probable. This process includes linking all derivatives that are designated as hedges of the variability of cash flows that are to be received or paid in connection with either a recognized asset or liability, firm commitment or forecasted transaction (“cash flow hedges”) to assets or liabilities in the Consolidated Statements of Financial Condition, firm commitments or forecasted transactions.

The Company generally uses the change in variable cash flows method to assess hedge effectiveness on a quarterly basis. The Company assesses effectiveness on a quarterly basis by evaluating whether the critical terms of the hedging instrument and the forecasted transaction have changed during the period and by evaluating the continued ability of the counterparty to honor its obligations under the contractual terms of the derivative. When the critical terms of the hedging instrument and the forecasted transaction do not match at inception, the Company may use regression or other statistical analyses to assess effectiveness.

For a qualifying cash flow hedge, changes in the fair value of the derivative, to the extent that the hedge is effective, are recorded within accumulated other comprehensive income (loss) in the Consolidated Statements of Financial Condition and are reclassified to interest expense in the Consolidated Statements of Income (Loss) when the underlying transactions (interest payments) have an impact on earnings. Cash flows are classified in the same category as cash flows from the hedged floating rate debt in the Consolidated Statements of Cash Flows.

Income taxes are accounted for using the asset and liability method of accounting. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences on differences between the carrying amounts of assets and liabilities and their respective tax basis, using tax rates in effect for the year in which the differences are expected to reverse. The effect on deferred assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted. Deferred tax assets are reduced by a valuation allowance when it is “more-likely-than not” that some portion or all of the deferred tax assets will not be realized. The realization of the deferred tax assets is dependent on the amount of the Company’s future taxable income.

The Company recognizes interest and penalties related to the underpayment of income taxes, including those resulting from the late filing of tax returns within the provision for income taxes in the Consolidated Statements of Income (Loss). The Company has not incurred a significant amount of interest or penalties in any of the periods presented.

GCMH is treated as a partnership for U.S. federal income tax purposes, and is subject to various state and local taxes. GCMH Equityholders, as applicable, are taxed individually on their share of the earnings; therefore, the Company does not record a provision for U.S. federal income taxes on the GCMH Equityholders’ share of the earnings. The Company is subject to U.S. federal, applicable state corporate and foreign income taxes, including with respect to its allocable share of any taxable income of GCMH.

In connection with the Transaction as described in Note 1, GCMG entered into a Tax Receivable Agreement with the GCMH Equityholders that will provide for payment by GCMG to the GCMH Equityholders of 85% of the amount of the tax savings, if any, that GCMG realizes (or, under certain circumstances, is deemed to realize) as a result of, or attributable to, (i) increases in the tax basis of assets owned directly or indirectly by GCMH or its subsidiaries from, among other things, any redemptions or exchanges of GCMH common shares (ii) existing tax basis (including amortization deductions arising from such tax basis) in intangible assets owned directly or indirectly by GCMH and its subsidiaries, and (iii) certain other tax benefits (including deductions in respect of imputed interest) related to GCMG making payments under the Tax Receivable Agreement.

Earnings (Loss) Per Share

The Company determines earnings (loss) per share in accordance with ASC 260, Earnings Per Share. The two-class method of computing earnings (loss) per share is required for entities that have participating securities. The Company’s Class C Common Stock has no economic interest in the earnings of the Company and the Company’s outstanding RSUs do not receive non-forfeitable dividends. As a result, the two-class method is not applicable.

The Company computes basic earnings (loss) per share by dividing net income (loss) attributable to GCMG by the weighted average number of shares outstanding for the applicable period. When calculating diluted earnings (loss) per share, the Company applies the treasury stock method and if-converted method, as applicable, to the warrants, the exchangeable common units of the Partnership and the RSUs to determine the diluted net income (loss) attributable to GCMG and the dilutive weighted-average common units outstanding.

Comprehensive Income

Comprehensive income consists of net income (loss) and other comprehensive income (loss). The Company’s other comprehensive income (loss) is comprised of unrealized gains and losses on cash flow hedges and foreign currency translation adjustments.

Segments

Management has determined the Company consists of a single operating and reportable segment. This is consistent with how the chief operating decision maker, who is the Chief Executive Officer, allocates resources and assesses performance.

Concentrations of Risk

The Company has a client base that is diversified across a range of different types of institutional clients and individual investors. The institutional client base consists primarily of public, corporate and Taft-Hartley pension funds as well as banks, insurance companies, sovereign entities, foundations and endowments. The client base is also geographically diversified with concentrations in North America, Asia, the Middle East, Europe, and Australia.

Long-lived assets attributed to locations outside of the U.S. are immaterial.

Recently Issued Accounting Standards

Recently Issued Accounting Standards - Adopted in Current Reporting Period

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires enhanced income tax disclosures including disclosures of specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold, additional disclosures about income taxes paid, and disclosure of pre-tax income or loss from continuing operations disaggregated between domestic and foreign income or loss. This guidance is effective for public business entities for fiscal years beginning after December 15, 2024. The Company adopted this standard on December 31, 2025 on a retrospective basis and implemented the applicable disclosure requirements for the year ended December 31, 2025. Adoption of ASU 2023-09 did not have an impact on the Consolidated Statements of Financial Condition, Consolidated Statements of Comprehensive Income (Loss), or Consolidated Statements of Cash Flows. Refer to Note 18 to our Consolidated Financial Statements for related disclosures.

Recently Issued Accounting Standards – To be Adopted in Future Periods

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. ASU 2024-03 requires public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. ASU 2025-06 replaces the previous development stage model with guidance that requires capitalization of internal-use software costs once a project has been authorized and funding has been committed, provided completion is considered probable. ASU 2025-06 is effective for fiscal years beginning after December 15, 2027, and for interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-06.

In December 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements. ASU 2025-09 clarifies certain aspects of the hedge accounting guidance and addresses incremental issues that emerged following ASU 2017-12 and the global reference rate reform initiative, with the objective of more closely aligning hedge accounting with the economics of an entity’s risk management activities. The amendments include updates related to assessing similar risk exposure for cash flow hedge groups, hedging variable interest payments on choose-your-rate debt structures, hedging components of nonfinancial forecasted transactions, the use of certain net written option strategies, and the accounting for foreign-currency-denominated debt in dual hedging relationships. ASU 2025-09 is effective for fiscal years beginning after December 15, 2026, and for interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-09.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. ASU 2025-11 clarifies the applicability and organization of interim reporting disclosure requirements and introduces a disclosure principle requiring entities to disclose events occurring since the end of the most recent annual reporting period that have a material impact on the entity, with the objective of improving the consistency and clarity of interim financial reporting. The amendments also provide a comprehensive list of disclosures required in interim financial statements prepared in accordance with U.S. GAAP but do not change the fundamental nature of interim reporting or expand existing disclosure requirements. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, and for interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11.

  1. Revenues

For the years ended December 31, 2025, 2024 and 2023, management fees and incentive fees consisted of the following:

Year Ended December 31,
Management fees202520242023
Management fees, net$407,978$386,954$360,888
Fund expense reimbursement revenue17,81414,69414,556
Total management fees$425,792$401,648$375,444
Year Ended December 31,
Incentive fees202520242023
Performance fees$68,245$55,323$15,313
Carried interest55,25750,91449,590
Total incentive fees$123,502$106,237$64,903

The Company recognized revenues during the years ended December 31, 2025, 2024 and 2023 of $0.9 million, $1.2 million and $0.5 million, respectively, that were previously received and deferred at the beginning of the respective periods.

  1. Investments

Investments consist of the following:

As of December 31,
20252024
Equity method investments$255,740$245,567
Other investments19,57312,240
Total investments$275,313$257,807

As of December 31, 2025 and 2024, the Company held investments of $275.3 million and $257.8 million, respectively, of which $40.5 million and $49.0 million were owned by noncontrolling interest holders, respectively. Future net income (loss) and cash flow from investments held by noncontrolling interest holders will not be attributable to the Company.

Equity Method Investments

The summarized financial information of the Company’s equity method investments is as follows:

As of December 31,
20252024
Total assets$51,402,892$46,382,280
Total liabilities$2,295,655$1,771,980
Total equity$49,107,237$44,610,300
Year Ended December 31,
202520242023
Investment income$234,102$243,222$187,989
Expenses460,021395,748347,320
Net investment loss(225,919)(152,526)(159,331)
Net realized and unrealized gain3,947,1562,737,0151,831,634
Net income$3,721,237$2,584,489$1,672,303

On February 28, 2025, the Company closed a joint venture, Grove Lane Partners LLC (“Grove Lane”), a premier distribution platform to broaden individual investor access to alternative investments. Upon closing, the Company made a total capital commitment of $15.0 million in exchange for 49% interest in Grove Lane, which is accounted for using the equity method of accounting. Under the terms of the joint venture agreement, the Company maintains the right, but not the obligation, to purchase the remaining 51% interest at a future date based on an agreed upon future value. As of December 31, 2025, the Company has funded $3.5 million of its capital commitment.

The Company evaluates each of its equity method investments, individually and in aggregate, to determine if any were significant as defined by the SEC.

As of December 31, 2025 and 2024, no individual equity method investment held by the Company met the significance criteria. As such, the Company is not required to present separate financial statements for any of its equity method investments.

Other Investments

See Note 5 for fair value disclosures of certain investments held within other investments. The Company also holds $0.1 million and $0.2 million of other investments not held at fair value held within other investments as of December 31, 2025 and 2024, respectively.

  1. Fair Value Measurements

The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis and level of inputs used for such measurements as of December 31, 2025 and 2024:

Fair Value as of December 31, 2025
Level 1Level 2Level 3Total
Assets
Money market funds$202,553$—$—$202,553
Other investments——19,46219,462
Total assets$202,553$—$19,462$222,015
Liabilities
Interest rate derivatives$—$10,694$—$10,694
Total liabilities$—$10,694$—$10,694
Fair Value as of December 31, 2024
Level 1Level 2Level 3Total
Assets
Money market funds$43,804$—$—$43,804
Other investments——11,99311,993
Total assets$43,804$—$11,993$55,797
Liabilities
Public warrants$21,149$—$—$21,149
Private warrants——1,3611,361
Interest rate derivatives—3,532—3,532
Total liabilities$21,149$3,532$1,361$26,042

Money Market Funds

Money market funds are valued using quoted market prices and are included in cash and cash equivalents in the Consolidated Statements of Financial Condition.

Interest Rate Derivatives

Management determines the fair value of its interest rate derivative agreements based on the present value of expected future cash flows based on observable future rates applicable to each swap contract using linear interpolation, inclusive of the risk of non-performance, using a discount rate appropriate for the duration. See Note 14 for additional information regarding interest rate derivatives.

Other Investments

Investments in the subordinated notes of structured alternatives investment solutions are not publicly traded and are classified as Level 3. Management determines the fair value of these other investments using a discounted cash flow analysis (“Cash Flow Analysis”), which includes assumptions regarding the expected deployment and realization timing of private investments. These positions were classified as Level 3 as of December 31, 2025 and 2024 because of the use of significant unobservable inputs in the Cash Flow Analysis as follows:

December 31, 2025 · December 31, 2024 · Impact to Valuation from an Increase in Input(2)
Significant Unobservable Inputs(1) · Range · Weighted Average · Range · Weighted Average
Discount rate(3)25.3% - 30.8%26.9%25.8% - 27.8%26.8%Decrease
Expected remaining term (years)4 – 11N/A8 – 12N/ADecrease
Expected total value to paid in capital – private assets(4)1.44x – 2.18x1.78x1.55x – 2.13x1.87x5Increase

(1)In determining these inputs, management considers the following factors including, but not limited to: liquidity, estimated yield, capital deployment, diversified multi-strategy appreciation, expected net multiple of investment capital across private assets investments, annual operating expenses, as well as investment guidelines such as concentration limits, position size, and investment periods.

(2)Unless otherwise noted, this column represents the directional change in fair value of the Level 3 investments that would result from an increase to the corresponding unobservable input. A decrease to the unobservable input would have the opposite effect.

(3)The discount rate was based on the relevant benchmark rate, spread, and yield migrations on related securitized assets.

(4)Inputs were weighted based on actual and estimated commitments to the respective private asset investments included in the range.

The resulting fair values of $19.5 million and $12.0 million were recorded within investments in the Consolidated Statements of Financial Condition as of December 31, 2025 and 2024, respectively.

The following table presents changes in Level 3 assets measured at fair value for the years ended December 31, 2025 and 2024.

Year Ended December 31,
20252024
Balance at beginning of period$11,993$11,192
Purchases3,601—
Change in fair value3,868801
Balance at end of period$19,462$11,993

Public Warrants

All outstanding public warrants were exercised or expired unexercised during the year ended December 31, 2025. Prior to exercise, the public warrants were valued using quoted market prices on the Nasdaq Stock Market LLC under the ticker GCMGW. See Note 8 for additional information regarding the warrant activity.

Private Warrants

All outstanding private warrants were exercised during the year ended December 31, 2025. Prior to exercise, the private warrants were classified as Level 3 as of December 31, 2024 because of the use of significant unobservable inputs in the valuation, however the overall private warrant valuation and change in fair value are not material to the Consolidated Financial Statements.

The valuations for the private warrants were determined to be $1.51 per unit as of December 31 2024. The resulting fair value of $1.4 million was recorded within warrant liabilities in the Consolidated Statements of Financial Condition as of December 31, 2024. Asno private warrants remained outstanding as of December 31, 2025, no liability was recorded. See Note 8 for additional information regarding the warrant activity.

The following table presents changes in Level 3 liabilities measured at fair value for the years ended December 31, 2025 and 2024:

Year Ended December 31,
20252024
Balance at beginning of period$1,361$389
Exercise of warrants(81)—
Change in fair value(1,280)972
Balance at end of period$—$1,361
  1. Intangible Assets

Intangible assets, net consist of the following:

As of December 31, 2025
Gross carrying amountAccumulated amortizationNet carrying amount
Subject to amortization:
Investment management contracts$36,190$(36,190)$—
Customer relationships23,518(23,518)—
Technology2,030(2,030)—
Other620(620)—
$62,358$(62,358)$—
As of December 31, 2024
Gross carrying amountAccumulated amortizationNet carrying amount
Subject to amortization:
Investment management contracts$36,190$(36,190)$—
Customer relationships23,518(22,204)1,314
Technology2,030(2,030)—
Other620(620)—
$62,358$(61,044)$1,314

Amortization expense related to intangible assets of $1.3 million, $1.3 million and $1.3 million was recognized for the years ended December 31, 2025, 2024 and 2023, respectively.

There is no future amortization expense relating to intangible assets, as of December 31, 2025.

  1. Equity

The Company hasone class of preferred stock authorized, three classes of common stock authorized: Class A common stock, Class B common stock and Class C common stock, and warrants. See Note 8 for additional information regarding the warrants. Holders of Class A common stock and Class C common stock vote together as a single class on all matters submitted to the stockholders for their vote or approval, except as required by applicable law.

Preferred Stock

The Company is authorized to issue 100,000,000 shares of preferred stock with a par value of $0.0001 per share. Voting and other rights and preferences may be determined from time to time by the Company’s Board of Directors. As of December 31, 2025 and 2024, there wereno shares of preferred stock issued or outstanding.

Class A Common Stock

Holders of Class A common stock are entitled toone vote for each share on all matters submitted to the stockholders for their vote or approval. Additionally, holders of shares of Class A common stock are entitled to receive dividends as and if declared by the Board of Directors out of legally available funds.

Class B Common Stock

Holders of Class B common stock are not entitled to any votes on any matter that is submitted to a vote by the Company’s stockholders, except as required by Delaware law. Delaware law would permit holders of Class B common stock to vote, withone vote per share, on a matter if it were to (i) change the par value of the Class B common stock or (ii) amend the Charter to alter the powers, preferences, or special rights of the Class B common stock as a whole in a way that would adversely affect the holders of Class B common stock. Holders of shares of Class B common stock are entitled to receive dividends as and if declared by the Board of Directors out of legally available funds. As of December 31, 2025 and 2024, there wereno shares of Class B comm stock issued or outstanding.

Class C Common Stock

Holders of Class C common stock are entitled to carry up to 10 votes per share and represent no more than 75% of the voting power of the total voting stock. Holders of Class C common stock do not have any right to receive dividends other than stock dividends consisting of shares of Class C common stock, paid proportionally with respect to each outstanding share of Class C common stock.

Shares of Class C common stock are cancelled upon a sale or transfer of Class A common stock received as a result of any redemption or exchange of GCMH common units outstanding to any person that is not the Chairman of the Board and Chief Executive Officer of the Company or GCMH Equityholders (or affiliate or owner) as of November 17, 2020. Additionally, shares of Class C common stock are cancelled if there is a redemption or exchange of a common unit for cash.

The GCMH Equityholders may from time to time cause GCMH to redeem any or all of their GCMH common units in exchange, at the Company’s election, for either cash (based on the market price for a share of the Class A common stock) or shares of Class A common stock.

Shares of Class A common stock, Class B common stock and Class C common stock are not subject to any conversion right.

Shares of Common Stock Outstanding

The following table shows a rollforward of the common stock outstanding for the years ended December 31, 2025, 2024 and 2023:

Class A common stockClass B common stockClass C common stock
December 31, 202241,806,215—144,235,246
Net shares delivered for vested RSUs1,746,537——
Repurchase of Class A shares(564,189)——
December 31, 202342,988,563—144,235,246
Net shares delivered for vested RSUs1,910,683——
December 31, 202444,899,246—144,235,246
Exercise of warrants10,417,322——
Issuance of Class A common stock3,752,965——
Net shares delivered for vested RSUs1,841,458——
Exchange of Partnership units for Class A common stock and cancellation of Class C common stock2,569,415—(2,569,415)
Repurchase of Class A shares(2,758,725)——
December 31, 202560,721,681—141,665,831

During the year ended December 31, 2025,10,410,334 public warrants were exercised resulting in $119.7 million of proceeds. There wereno public warrants exercised during the year ended December 31, 2024 and 2023, respectively. During the year ended December 31, 2025,900,000 private warrants were exercised, resulting in the issuance of 6,988 shares of Class A common stock pursuant to the election of the cashless basis exercise. See Note 8 for additional information on the Company’s warrant activity.

During the year ended December 31, 2025, the Company entered into a Share Purchase Agreement with Sumitomo Mitsui Trust Bank, Limited (“SuMi Trust”) for the issuance and sale in a registered direct offering of 3,752,965 shares of the Company’s Class A common stock to SuMi Trust at an offering price of $13.322799 per share, which represented the 10-day volume-weighted average price of our Class A common stock ending March 31, 2025, for net proceeds of $49.8 million. The transaction was closed on April 22, 2025.

As of December 31, 2025,365,304 RSUs were vested, but not yet delivered, and are therefore not yet included in outstanding Class A common stock. The delivery of vested RSUs will be reduced by the number of shares withheld to satisfy statutory withholding tax obligations, as well as RSUs that are settled in cash. See Note 12 for additional information on the Company’s RSUs.

During the year ended December 31, 2025, the Company exchanged 2,569,415 Partnership common units for 2,569,415 shares of Class A common stockto deliver in settlement of the vested GCMH Equityholders Awards. At the same time,2,569,415 shares of Class C common stock were cancelled. This conversion did not result in any cash transferred. As of December 31, 2025,4,400,000 GCMH Equityholders Awards were vested, but not yet delivered, and are therefore not yet included in outstanding Class A common stock. See Note 11 for additional information on the Company’s GCMH Equityholders Awards.

The Company records a reallocation adjustment between GCMG equity and Non-controlling interests in GCMH to reflect the impact of changes in economic ownership percentages during the respective period and adjust previously recorded equity transactions to the economic ownership percentage as of the end of each reporting period.

At-the-Market Equity Program

On November 17, 2025, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Morgan Stanley & Co. LLC (the “Agent”), pursuant to which the Company may issue and sell up to $100.0 million in shares of our Class A common stock through an at-the-market (“ATM”) equity program. Also on November 17, 2025, the Company filed a prospectus supplement relating to this ATM equity sales program concurrently.

The Company didnot issue any shares under the ATM equity program during the year ended December 31, 2025.

Dividends

Dividends are reflected in the Consolidated Statements of Equity (Deficit) when declared by the Board of Directors. The table below summarizes dividends declared during 2025, 2024 and 2023:

Declaration DateRecord DatePayment DateDividend per Common Share
February 9, 2023March 1, 2023March 15, 2023$0.11
May 9, 2023June 1, 2023June 15, 2023$0.11
August 8, 2023September 1, 2023September 15, 2023$0.11
November 7, 2023December 1, 2023December 15, 2023$0.11
Total dividends paid per share, year ended December 31, 2023$0.44
February 8, 2024March 1, 2024March 15, 2024$0.11
May 6, 2024June 3, 2024June 17, 2024$0.11
August 7, 2024September 3, 2024September 17, 2024$0.11
November 7, 2024December 2, 2024December 16, 2024$0.11
Total dividends paid per share, year ended December 31, 2024$0.44
February 6, 2025March 3, 2025March 17, 2025$0.11
May 5, 2025June 6, 2025June 16, 2025$0.11
August 4, 2025September 2, 2025September 16, 2025$0.11
October 14, 2025December 1, 2025December 15, 2025$0.12
Total dividends paid per share, year ended December 31, 2025$0.45

Dividend equivalent payments of $3.4 million and $2.1 million were accrued for holders of undelivered RSUs as of December 31, 2025 and 2024, respectively. Distributions to partners represent distributions made to GCMH Equityholders.

Stock Repurchase Plan

On August 6, 2021, GCMG’s Board of Directors authorized a stock repurchase plan, which may be used to repurchase shares of the Company’s outstanding Class A common stock and, until November 17, 2025, warrants to purchase shares of Class A common stock. Class A common stock may be repurchased from time to time in open market transactions, in privately negotiated transactions, including with employees or otherwise, pursuant to the requirements of Rule 10b5-1 and Rule 10b-18 of the Exchange Act, as well as to retire (by cash settlement or the payment of tax withholding amounts upon net settlement) equity-based awards granted under our 2020 Incentive Award Plan, as amended and restated (and any successor plan thereto), with the terms and conditions of these repurchases depending on legal requirements, price, market and economic conditions and other factors. The Company is not obligated under the terms of the plan to repurchase any of its Class A common stock, the program has no expiration date, and the Company may suspend or terminate the program at any time without prior notice. Any shares of Class A common stock repurchased as part of this program will be canceled. GCMG’s Board of Directors has made subsequent increases to its original stock repurchase authorization amount for shares and, until November 17, 2025, warrants. As of December 31, 2024, the total authorization was $140 million, excluding fees and expenses. On February 6, 2025, GCMG’s Board of Directors increased the firm’s existing repurchase authorization by $50 million, from$140 millionto$190 million. On August 4, 2025, GCMG’s Board of Directors further increased the firm’s existing repurchase authorization by $30 million, from $190 million to $220 million. On February 9, 2026, GCMG’s Board of Directors further increased the firm’s existing repurchase authorization by $35 million, from $220 million to $255 million.

The table below presents information about deemed repurchases for RSUs that were settled in cash and shares retired in connection with the net share settlement of equity-based awards. See Note 12 for additional information regarding RSUs.

Year Ended December 31,
202520242023
Deemed repurchases of Class A common stock2,032,0803,510,2763,289,385
Average cost per deemed repurchase of Class A common stock$12.63$9.44$7.85
Total cost of deemed repurchases$25,663$33,152$25,835

The Company did not repurchase any public or private warrants during the years ended December 31, 2025, 2024 and 2023.

The table below presents information about Class A common stock repurchased on the open market.

Year Ended December 31,
202520242023
Class A common stock2,758,725—564,189
Average cost per share$11.11$—$7.94
Total cost of Class A common stock repurchases$30,657$—$4,478

As of December 31, 2025, the Company had $55.7 million remaining under the stock repurchase plan.

  1. Warrants

Public Warrants

The Company originally issued public warrants in connection with the Transaction, each entitling the holder toone share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment. A warrant holder may have exercised its warrants only for a whole number of shares of Class A common stock. This means that only a whole warrant could have been exercised at any given time by a warrant holder. The warrants expired 5 years after the consummation of the Transaction, on November 17, 2025.

Warrant holders did not have the rights or privileges of holders of Class A common stock nor any voting rights until they exercised their warrants and received shares of Class A common stock. After the issuance of shares of Class A common stock, upon exercise of the warrants, each holder is entitled toone vote for each share held of record on all matters to be voted on by stockholders.

Private Placement Warrants

The private placement warrants (including the Class A common stock issuable upon exercise of the private placement warrants) were exercisable on a cashless basis by CF Sponsor, Holdings or their permitted transferees. The holders of the private placement warrants elected to exercise the private placement warrants on a cashless basis.

The following table shows a rollforward of the public and private warrants outstanding for the years ended December 31, 2025, 2024 and 2023:

Public WarrantsPrivate WarrantsTotal
December 31, 202216,784,970900,00017,684,970
Exercised———
Repurchased———
December 31, 202316,784,970900,00017,684,970
Exercised———
Repurchased———
December 31, 202416,784,970900,00017,684,970
Exercised(10,410,334)(900,000)(11,310,334)
Expired(6,374,636)—(6,374,636)
December 31, 2025———

During the year ended December 31, 2025,10,410,334 public warrants were exercised, resulting in the issuance of 10,410,334 shares of Class A common stock and cash proceeds of $119.7 million. Also during the year ended December 31, 2025,900,000 private warrants were exercised, resulting in the issuance of 6,988 shares of Class A common stock pursuant to the election of the cashless basis exercise. During the years ended December 31, 2025, 2024 and 2023, pursuant to the stock repurchase plan described in Note 7, no warrants were repurchased. All remaining unexercised warrants expired in accordance with their terms on November 17, 2025 and terminated with no value. No warrants remained outstanding as of December 31, 2025.

  1. Variable Interest Entities

The Company consolidates VIEs when it determines that it is the primary beneficiary. Based on this assessment, the Company consolidates a certain VIE in the Consolidated Statements of Financial Condition. Creditors (or beneficial interest holders) of the VIEs do not have recourse to the Company’s general credit. As of December 31, 2024, the consolidated VIE did not have any assets or liabilities.

The carrying amounts of the consolidated VIE’s assets and liabilities, adjusting for intercompany eliminations, were as follows:

As of
December 31, 2025
Assets
Cash and cash equivalents$2,497
Management fees receivable449
Other assets302
Total assets$3,248
Liabilities
Accrued expenses and other liabilities$234
Total liabilities$234

The Company holds variable interests in certain entities that are VIEs which are not consolidated, as it is determined that the Company is not the primary beneficiary. The Company’s involvement with such entities is generally in the form of direct equity interests in, and fee arrangements with, the entities in which it also serves as the general partner or managing member. The Company evaluated its variable interests in the VIEs and determined it is not considered the primary beneficiary of the entities primarily because it does not have interests in the entities that could potentially be significant. No reconsideration events that caused a change in the Company’s consolidation conclusions occurred during either the year ended December 31, 2025 or 2024. As of December 31, 2025 and 2024, the total unfunded commitments from the special limited partner and general partners to the unconsolidated VIEs were $88.3 million and $51.6 million, respectively. These commitments are the primary source of financing for the unconsolidated VIEs.

The following table sets forth certain information regarding the VIEs in which the Company holds a variable interest but does not consolidate. The assets recognized on the Company’s Consolidated Statements of Financial Condition relate to the Company’s interests in and management fees, incentive fees and third party costs receivables from these non-consolidated VIEs. The Company’s maximum exposure to loss relating to non-consolidated VIEs as of December 31, 2025 and 2024 were as follows:

As of December 31,
20252024
Investments$121,572$125,504
Receivables12,38719,126
Maximum exposure to loss$133,959$144,630

The above table includes investments in VIEs which are owned by noncontrolling interest holders of approximately $22.0 million and $35.4 million as of December 31, 2025 and 2024, respectively.

  1. Premises and Equipment

A summary of premises and equipment as of December 31, 2025 and 2024 is as follows:

As of December 31, · Estimated Useful Lives
2025 · 2024
Furniture, fixtures and leasehold improvements$54,138$47,5713 – 12 years
Office equipment3272445 years
Computer equipment and software10,07110,0513 – 5 years
Aircraft1,5501,5505 years
Assets in progress3,3551,351N/A
Premises and equipment, at cost69,44160,767
Accumulated depreciation and amortization(39,553)(38,084)
Premises and equipment, net$29,888$22,683

Total depreciation and amortization expense related to premises and equipment of $3.1 million, $2.0 million and $1.4 million was recognized for the years ended December 31, 2025, 2024 and 2023, respectively.

  1. Employee Compensation and Benefits

For the years ended December 31, 2025, 2024 and 2023, employee compensation and benefits consisted of the following:

Year Ended December 31,
202520242023
Cash-based employee compensation and benefits$151,213$148,547$156,153
Equity-based compensation45,59948,15850,667
Partnership interest-based compensation46,18172,068103,934
Carried interest compensation31,37430,45028,505
Cash-based incentive fee related compensation44,51736,45515,628
Other non-cash compensation4485581,157
Total employee compensation and benefits$319,332$336,236$356,044

Partnership Interest in Holdings, Holdings II and Management LLC

Payments and settlements for partnership interest awards to the employees are made by GCMH Equityholders. As a result, the Company records a non-cash profits interest compensation charge and an offsetting deemed contribution to equity (deficit) to reflect the payments or settlements made or owed by the GCMH Equityholders. Since payments or settlements are made by Holdings, Holdings II and Management LLC, the expense that is pushed down to GCMH and the offsetting deemed contribution are each attributed solely to noncontrolling interests in GCMH. Any liability related to the awards is recognized at Holdings, Holdings II or Management LLC as Holdings, Holdings II or Management LLC is the party responsible for satisfying the obligation, and is not shown in the Company’s Consolidated Financial Statements. The Company has recorded deemed contributions to equity (deficit) from Holdings, Holdings II and Management LLC of $46.2 million, $72.1 million and $103.9 million for the years ended December 31, 2025, 2024 and 2023, respectively, for partnership interest-based compensation expense, which was or will ultimately be paid or settled by Holdings, Holdings II or Management LLC.

GCMH Equityholders have modified awards to certain individuals upon their voluntary retirement or intention to retire as employees. These awards generally include a stated target amount that, upon payment, terminates the recipient’s rights to future distributions and allows for a lump sum buy-out of the awards, at the discretion of the managing member of Holdings, Holdings II, and Management LLC. The awards are accounted for as partnership interest-based compensation at the fair value of these expected future payments, in the period the employees accepted the offer when there is no continued service required. The Company recognized partnership interest-based compensation expense related to award modifications of $15.4 million and $18.5 million for the years ended December 31, 2025 and 2024, respectively. No partnership interest-based compensation expense related to award modifications was recognized for the year ended December 31, 2023 (other than as discussed for the Holdings Awards below).

The liability associated with awards that contain a stated target has been retained by Holdings as of December 31, 2025 and 2024 and is re-measured at each reporting date, with any corresponding changes in liability being reflected as employee compensation and benefits expense of the Company. Certain recipients had unvested stated target payments of $25.6 million as of December 31, 2025, which will be reflected as employee compensation and benefits expense by the Company over the service period. No recipients had unvested stated target payments as of either December 31, 2024 and 2023, respectively. The Company recognized partnership interest-based compensation expense of $25.2 million, $16.8 million and $21.4 million for the years ended December 31, 2025, 2024 and 2023, respectively, related to profits interest awards that are in substance profit-sharing arrangements.

GCMH Equityholders Awards

In the year ended December 31, 2022, GCMH Equityholders entered into agreements that will transfer equity ownership between certain existing employee members of the GCMH Equityholders (“GCMH Equityholders Awards”). The GCMH Equityholders Awards will entitle recipients to receive Class A common stock upon vesting. The non-cash awards serve to transfer equity ownership from existing GCMH Equityholders to other existing member employees upon vesting. The GCMH Equityholders Awards did not dilute Class A common stockholders and did not impact cash flows of the Company. The GCMH Equityholders Awards are accounted for under ASC 718, Compensation—Stock Compensation. The awards vested in May 2025 and do not entitle the recipients to dividends or distributions made on Class A common stock until delivery. As such, the fair value of the GCMH Equityholders Awards is based on the closing price of Class A common stock on the accounting grant date less the present value of dividends expected to be paid during the vesting period. GCMH Equityholders can settle the awards at various dates after vesting by exchanging outstanding GCMH common units or by otherwise acquiring and delivering Class A common stock, and therefore the vesting of such awards will not dilute Class A common stockholders. As such, the expense that is pushed down to GCMH and the offsetting deemed contribution are each attributed solely to noncontrolling interests in GCMH, consistent with the accounting for payments to employees described above. The GCMH Equityholders Awards of 7,169,415 units had an aggregate grant date fair value of $53.4 million, or an average grant date fair value of $7.45 per unit. See Note 12 for additional information on a modified GCMH Equityholder Award during the year ended December 31, 2025. The Company recognized partnership interest-based compensation expense related to the GCMH Equityholders Awards of $5.6 million, $21.9 million, and $21.9 million for the years ended December 31, 2025, 2024, and 2023, respectively. All compensation expense related to the GCMH Equityholder Awards has been recognized.

Holdings Awards

On May 9, 2023, Holdings entered into amended and restated participation certificates with existing employee members (“Holdings Awards”). The Holdings Awards entitle recipients to a stated percentage, or minimum allocable share, of distributions from Holdings, as well as a profits interest with respect to net sale proceeds from dispositions of Holdings properties after certain threshold distributions to other members. Pursuant to ASC 505, the Holdings Awards will be recognized as compensation expense with a corresponding deemed contribution and are accounted for under ASC 718, Compensation—Stock Compensation as the awards have characteristics that are more akin to the risks and rewards of equity ownership in Holdings. These awards do not dilute Class A common stockholders or impact net cash flows of the Company.

Certain of these existing employee members were previously awarded target amounts that entitled them to a stated percentage, or minimum allocable share, of distributions from Holdings until they received a sum certain. Those target amounts represented by those sums, which were previously recorded as partnership interest-based compensation, were reduced to zero in the amended and restated participation certificates. As a result, target amounts that were previously recorded as partnership interest-based compensation were reversed, while partnership interest-based compensation associated with the amended and restated participation certificates is recorded.

The Holdings Awards had an aggregate grant date fair value of $155.5 million, which was partially offset when recognized in expense by$80.0 million target amounts reversed during the year ended December 31, 2023. The fair value of the Holdings Awards was determined by a third-party valuation firm utilizing a discounted cash flow analysis for the minimum allocable share and a Monte Carlo simulation valuation model for the profits interest with respect to net sale proceeds from dispositions of Holdings properties after the threshold distributions. Significant valuation inputs and assumptions included Holdings projected financial information and distributions, an estimated 10 year holding period, a 15.4% cost of equity, a 13.0% weighted average cost of capital, a 35% volatility assumption, the likelihood of a defined conversion event, a 40% discount for lack of marketability, and the fair value of reference properties that determine the threshold distributions for the profits interest with respect to net sale proceeds. The resulting fair value of the Holdings Awards is pushed down from Holdings to the Company and recorded as compensation expense. A portion of the Holdings Awards were vested upon grant, resulting in immediate expense recognition. The Company recognized partnership interest-based compensation expense related to the Holdings Awards of $14.9 million and $60.6 million for the years ended December 31, 2024 and 2023, respectively. The Company didnot recognize any partnership interest-based compensation expense related to the Holdings Awards for the year ended December 31, 2025 as all compensation expense related to the Holdings Awards was previously recognized.

Other

Other consists of employee compensation and benefits expense related to deferred compensation programs and other awards that represent investments made in GCM Funds on behalf of the employees.

  1. Equity-Based Compensation

2020 Incentive Award Plan

During February 2021, the Company adopted the 2020 Incentive Award Plan. The 2020 Incentive Award Plan, as amended and restated, allows for the granting of stock options, stock appreciation rights, restricted stock awards, restricted stock units, and other stock or cash based awards or dividend equivalent awards to employees, directors and consultants.

Restricted Stock Units

During the year ended December 31, 2023, the Company granted 1.9 million equity-classified RSUs and 4.0 million liability-classified RSUs with aggregate grant date fair values of $15.8 million and$31.0 million, respectively, to certain employees.

During the year ended December 31, 2024, the Company granted 2.0 million equity-classified RSUs and 3.0 million liability-classified RSUs with aggregate grant date fair values of $17.7 million and$29.6 million, respectively, to certain employees.

During the year ended December 31, 2025, the Company granted 4.2 million equity-classified RSUs and 2.2 million liability-classified RSUs with aggregate grant date fair values of$55.1 million and$26.7 million, respectively, to certain employees.

Liability-classified RSUs are either classified as liabilities because they are required to be settled in cash or because the Company has the right to and intends to (as of the grant date or December 31, 2025, as applicable) settle the RSUs partially or wholly in cash. During the year ended December 31, 2025, the Company reclassified 1.6 million RSUs from liability-classified to equity-classified based on management’s intent to settle (or actual settlement of) the awards in shares of Class A common stock. The majority of liability-classified awards outstanding at December 31, 2025 were granted in November 2025 and vest on March 1, 2026.

Other than RSUs granted in November 2025, outstanding awards generally vest either (a) over aone tothree year period or (b) over athree toseven year period. Upon delivery, the Company may withhold the number of shares to satisfy the statutory withholding tax obligation and deliver the net number of resulting shares vested.

A summary of non-vested equity-classified RSU activity for the year ended December 31, 2025 is as follows:

Number of RSUsWeighted-Average Grant-Date Fair Value Per RSU
Balance as of December 31, 20243,251,068$8.40
Granted4,245,37912.98
Reclassified from liability-classified RSUs1,627,04111.54
Vested(3,182,638)10.23
Forfeited(289,853)11.19
Balance as of December 31, 20255,650,997$11.57

A summary of non-vested liability-classified RSU activity for the year ended December 31, 2025 is as follows:

Number of RSUsWeighted-Average Grant-Date Fair Value Per RSU
Balance as of December 31, 20241,813,249$10.50
Granted2,211,12312.09
Reclassified to equity-classified RSUs(1,627,041)11.54
Vested(746,691)11.66
Forfeited(1,742)12.92
Balance as of December 31, 20251,648,898$11.08

The total grant-date fair value of RSUs that vested during the years ended December 31, 2025, 2024 and 2023 was $41.3 million, $44.9 million and $51.0 million, respectively. For the years ended December 31, 2025, 2024 and 2023, $45.6 million, $48.2 million and $50.7 million, respectively, of compensation expense related to RSUs was recorded within employee compensation and benefits in the Consolidated Statements of Income (Loss). As of December 31, 2025, total unrecognized compensation expense related to unvested RSUs was $61.0 million and is expected to be recognized over the remaining weighted average period of 3.2 years.

During the year ended December 31, 2025, a modification of a GCMH Equityholder Award was made that changed settlement of 200,000 shares to be from the Company’s 2020 Incentive Award Plan. Such amount is reflected as granted and vested within the equity-classified RSU activity in the rollforward above.

See Note 11 for additional information regarding GCMH Equityholders Awards and Holdings Awards.

The tax benefit related to RSUs that vested and were delivered for the years ended December 31, 2025, 2024 and 2023, was $3.1 million, $3.0 million and $2.2 million, respectively.

On January 15, 2026, the Company granted 0.9 million liability-classified RSUs that vest on April 15, 2026.

  1. Debt

The table below summarizes the outstanding debt balance as of December 31, 2025 and 2024:

As of December 31,
20252024
Senior loan$431,430$435,810
Less: debt issuance costs(2,995)(3,771)
Total debt$428,435$432,039

Maturities of debt for the next five years and thereafter are as follows:

Year Ended December 31,
2026$4,380
20274,380
20284,380
20294,380
2030413,910
Thereafter—
Total$431,430

Senior Loan

On January 2, 2014, the Company entered into a senior secured term loan facility (“Senior Loan”) which was subsequently amended through several debt modifications.

In 2021, the Company amended its Senior Loan to extend the maturity date to February 24, 2028 and increased the aggregate principal amount thereunder to$400.0 million (“2028 Term Loans”).

Through June 30, 2023, the 2028 Term Loans had an interest rate margin of 2.50% over the LIBOR, subject to a 0.50% LIBOR floor. On June 29, 2023, the Company entered into Amendment No. 7 to the Credit Agreement to incorporate changes for the contemplated transition to the Term Secured Overnight Financing Rate (“Term SOFR”), and on July 1, 2023, in conjunction with a Benchmark Transition Event, the interest rate margin and floor defaulted to the Term SOFR plus a Benchmark Replacement Adjustment of 0.11% as recommended by the Relevant Governmental Body (all terms as defined in the Amended Credit Agreement).

On May 21, 2024, the Company entered into Amendment No. 8 to the Credit Agreement to, among other things, increase and extend the maturity of the 2028 Term Loans. The amendment increased the aggregate principal amount from

$388.0 million to $438.0 million, extended the maturity date from February 24, 2028 to February 25, 2030 (as increased and extended, the “2030 Term Loans”), decreased the interest rate margin to 2.25% over Term SOFR, and removed the Benchmark Replacement Adjustment of 0.11%. The 2030 Term Loans continue to be subject to a 0.50% SOFR floor. As a result of the amendment and extension, the Company capitalized$0.4 million of debt issuances costs related to payments to lenders, which is recorded within debt in the Consolidated Statements of Financial Condition, and expensed $3.0 million of third-party costs which is recorded within general, administrative and other in the Consolidated Statements of Income (Loss) for the year ended December 31, 2024. In addition, the Company recorded an expense of $0.2 million related to the partial extinguishment of certain lenders, which is recorded within other income (expense) in the Consolidated Statements of Income (Loss) for the year ended December 31, 2024.

From June 30, 2021 until May 21, 2024 quarterly principal payments of$1.0 million were required to be made toward the 2028 Term Loans (less any reduction for prior or future voluntary or mandatory prepayments of principal). As part of Amendment No. 8 to the Credit Agreement, quarterly principal payments of$1.1 million are required to be made toward the 2030 Term Loans beginning July 1, 2024 (less any reduction for prior or future voluntary or mandatory prepayments of principal).

In addition to the scheduled principal repayments, the Company is required to offer to make prepayments of Consolidated Excess Cash Flow (“Cash Flow Payments”) no later than five days following the date the quarterly financial statements are due if the leverage ratio exceeds certain thresholds in the Amended Credit Agreement No. 8. The Cash Flow Payments were calculated as defined in the Senior Loan agreement based on a percentage of calculated excess cash. During the years ended December 31, 2025, 2024 and 2023, the Company wasnot required to offer to make any Cash Flow Payments.

As of December 31, 2025 and 2024, $431.4 million and $435.8 million of 2030 Term Loans were outstanding, respectively, with weighted average interest rates of 6.50% and 7.54% for the years ended December 31, 2025 and 2024, respectively.

Under the credit and guaranty agreement governing the terms of the Senior Loan, the Company must maintain certain leverage and interest coverage ratios. The credit and guaranty agreement also contains other covenants that, among other things, restrict the ability of the Company and its subsidiaries to incur debt and restrict the Company and its subsidiaries ability to merge or consolidate, or sell or convey all or substantially all of the Company’s assets. As of December 31, 2025 and 2024, the Company was in compliance with all covenants.

GCMH Equityholders and IntermediateCo have executed a pledge agreement (“Pledge Agreement”) and security agreement (“Security Agreement”) with the lenders of the Senior Loan. Under the Pledge Agreement, GCMH Equityholders and IntermediateCo have agreed to secure the obligations under the Senior Loan by pledging its interests in GCMH as collateral against the repayment of the senior secured notes, and GCMH has agreed to secure the obligations under the Senior Loan by granting a security interest in and continuing lien on the collateral described in the Security Agreement. The Pledge Agreement and Security Agreement will remain in effect until such time as all obligations relating to the Senior Loan have been fulfilled.

In February 2026, the Company completed a prepayment of $65 million on our outstanding 2030 Term Loans.

Credit Facility

Concurrent with the issuance of the Senior Loan, the Company entered into a $50.0 million revolving credit facility (“Credit Facility”). The Credit Facility maturity date was extended from February 24, 2026 to February 24, 2028 as part of Amendment No. 8 to the Credit Agreement, and carries an unused commitment fee of up to 0.50% per annum. There wereno outstanding borrowings related to the Credit Facility as of each of December 31, 2025 and 2024.

Other

Certain subsidiaries of the Company agree to jointly and severally guarantee, as primary obligors and not merely as surety guarantees, the obligations of their parent entity, GCMH.

Amortization of deferred debt issuance costs was $0.8 million, $0.9 million and $1.1 million for the years ended December 31, 2025, 2024 and 2023, respectively. These amounts are recorded within interest expense in the Consolidated Statements of Income (Loss).

The carrying value of the Senior Loan, excluding the unamortized debt issuance costs presented as a reduction to the principal balance approximated the fair value as of December 31, 2025 and December 31, 2024. As the Senior Loan was not accounted for at fair value, it was not included in the Company’s fair value hierarchy in Note 5, however had it been included, it would have been classified in Level 2.

  1. Interest Rate Derivatives

The Company has entered into various derivative agreements with financial institutions to hedge interest rate risk related to its outstanding debt. The Company had the following interest rate derivatives recorded within accrued expenses and other liabilities as of December 31, 2025 and 2024 in the Consolidated Statements of Financial Condition.

DerivativeNotional AmountFair Value as of December 31, 2025Fair Value as of December 31, 2024Fixed Rate PaidFloating Rate ReceivedEffective Date(2)Maturity Date
Interest rate swap$300,000$(6,109)$(2,291)4.37%1 month Term SOFR(1)November 2022February 2028
Interest rate swap$28,500$(707)$(397)4.47%1 month Term SOFR(1)May 2024February 2028
Interest rate swap$317,000$(3,878)$(844)4.17%1 month Term SOFR(1)February 2028February 2030

(1)Floating rate received subject to a 0.50% floor.

(2)Represents the date at which the derivative is in effect and the Company is contractually required to begin payment of interest under the terms of the agreement.

A rollforward of the amounts in accumulated other comprehensive income (loss) (“AOCI”) related to interest rate derivatives designated as cash flow hedges is as follows:

Year Ended December 31,
202520242023
Derivative gain at beginning of period$18,342$21,806$29,130
Amount recognized in other comprehensive income(1)(6,184)7,0251,536
Amount reclassified from accumulated other comprehensive loss to interest expense(7,489)(10,489)(8,860)
Derivative gain at end of period4,66918,34221,806
Less: gain attributable to noncontrolling interests in GCMH4,40415,49618,267
Derivative gain at end of period, net$265$2,846$3,539

(1)Net of tax benefit of $1.1 million, $0.2 million, and $0.4 million for the years ended December 31, 2025, 2024, and 2023 respectively.

In February 2021, the Company terminated a derivative instrument which was entered into in 2017, and matured in 2023. In October 2022, the Company terminatedtwo derivative instruments that had notional balances of $232 million and $68 million, effective dates that started in 2021, and maturity dates in 2028. The Company received $40.3 million of cash for the fair market value of the interest rate swaps at termination in October 2022. The terminated derivative instrument were determined to be effective cash flow hedges at inception. The amounts previously recorded as hedges in AOCI related to previously terminated derivative instruments will remain in AOCI and will be recorded ininterest expensein the Consolidated Statements of Comprehensive Income (Loss) over the original lives of the derivative instruments.

The Company reclassified $7.6 million,$7.6 million, and $6.7 million for the years ended December 31, 2025, 2024, and 2023, respectively, from AOCI to interest expense, relating to the derivative instruments terminated that initially qualified for hedge accounting. The net impact of these reclassifications decreased interest expense for each of the years ended December 31, 2025, 2024, and 2023, respectively.

Effective on November 1, 2022, the Company entered into a swap agreement to hedge interest rate risk related to payments made for the 2028 Term Loans that has a notional amount of $300.0 million and a fixed rate of 4.37%. The swap agreement and the 2028 Term Loans had a 0.50% LIBOR floor through June 30, 2023 and defaulted to Term SOFR plus a Benchmark Replacement Adjustment on July 1, 2023 at the Benchmark Transition Event as discussed in Note 13. The swap was determined to be an effective cash flow hedge at inception based on a comparison of critical terms and remained an effective cash flow hedge at and following the Benchmark Transition Event.

Effective on May 31, 2024, the Company entered into a swap agreement to hedge interest rate risk related to payments made for the increase in aggregate principal amount of the 2030 Term Loans that has a notional amount of $28.5 million, and a fixed rate of 4.47%. The swap agreement and 2030 Term Loans have a 0.50% Term SOFR floor. The swap was determined to be an effective cash flow hedge at inception based on a comparison of critical terms.

On May 23, 2024, the Company entered into a forward-starting swap agreement to hedge interest rate risk related to payments made during the extended maturity of the 2030 Term Loans that has an effective date of February 2028, a notional amount of $317.0 million and a fixed rate of 4.17%. The forward-starting swap agreement and 2030 Term Loans have a 0.50% Term SOFR floor. The swap was determined to be an effective cash flow hedge at inception based on a comparison of critical terms.

The fair values of the interest rate swaps are based on observable market inputs and represent the net amount required to terminate the positions, taking into consideration market rates and non-performance risk. Refer to Note 5 for additional information.

During the next twelve months, the Company expects to reclassify approximately $4.6 million from AOCI to interest expense, which will decrease interest expense, including the impact of the swap terminations.

  1. Accrued Expenses and Other Liabilities

A summary of accrued expenses and other liabilities as of December 31, 2025 and 2024 is as follows:

As of December 31,
20252024
Carried interest payable$—$338
Deferred revenue10,1089,761
Clawback obligation200200
Derivative liability10,6943,532
Other liabilities22,31716,866
Total accrued expenses and other liabilities$43,319$30,697
  1. Commitments and Contingencies

Leases

The Company has entered into operating lease agreements for office space. The Company leases office space in various countries around the world and maintains its headquarters in Chicago, Illinois, where it leases primary office space. The leases contain rent escalation clauses based on increases in base rent, real estate taxes and operating expenses. Some leases offer the option to extend for an additional term or terminate early. The Company generally does not include options to renew when determining the lease term as it is not reasonably certain at contract inception that the Company will exercise the option(s). As the implicit rate is not generally readily determinable, the Company uses its incremental borrowing rate to determine the present value of future minimum lease payments. The Company’s leases have remaining lease terms of less thanone year to 14 years.

Operating lease costs are recorded within general, administrative and other and sublease income is recorded within other income (expense) in the Consolidated Statements of Income (Loss). The lease cost and sublease income components were as follows:

Years Ended December 31,
202520242023
Operating lease cost(1)$7,466$9,904$8,874
Variable lease cost(2)4,4143,8784,458
Less: sublease income208215179
Total lease cost$11,672$13,567$13,153

(1)Includes $0.3 million of short term lease expense for each of the years ended December 31, 2025, 2024, and 2023. For the years ended December 31, 2024 and 2023 includes lease cost fortwo offices in New York due to the build out of new office space.

(2)Includes common area maintenance charges and other variable costs not included in the measurement of ROU assets and lease liabilities.

The following table summarizes cash flows and other supplemental information related to our operating leases:

Years Ended December 31,
202520242023
Cash paid for amounts included in the measurement of operating lease liabilities(1)$7,979$5,132$8,613
Non-cash ROU assets obtained in exchange for new and extended operating leases$2,967$9,075$34,116
Weighted average remaining lease term in years12.8 years13.7 years13.1 years
Weighted average discount rate6.3%6.3%6.1%

(1)Excludes $6.3 million of cash received during the year ended December 31, 2024 for lease incentives received related to the New York office lease. Also excludes $0.2 million of cash paid during the year ended December 31, 2025 for lease termination payments related to the Chicago office lease.

As of December 31, 2025 the maturities of operating lease liabilities were as follows:

Year Ended December 31,
2026$6,127
20277,474
20287,371
20296,140
20306,497
Thereafter56,391
Total lease payments$90,000
Less: tenant improvement allowance(9,680)
Less: imputed interest(28,526)
Total operating lease liabilities$51,794

Commitments

The Company owns a 6.25% interest in an aircraft and was required to pay a fixed management fee of $0.3 million per year until 2024. On September 3, 2024, the Company extended its contract for a 6.25% interest in an aircraft until September 3, 2029, and will continue to pay a fixed management fee of $0.3 million per year.

The Company had $140.6 million and $90.5 million of unfunded investment commitments as of December 31, 2025 and 2024, respectively, representing general partner capital funding commitments to several of the GCM Funds and other commitments to our equity method investments.

Employee Investment Loan Program

Beginning in the year ended December 31, 2025, eligible employees may apply for loans from a third-party lender, which may, at its discretion, extend loans directly to such employees for purposes of funding capital calls to specified Company-managed investment vehicles. The loans are collateralized by the employees’ related investment interests and return-of-capital distributions from those investments are applied to reduce outstanding loan balances.

In connection with the loan program, the Company entered into a separate arrangement with the third-party lender that includes a buyback provision, which represents a performance guarantee under applicable accounting guidance. Under the buyback provision, the Company may be required, upon an employee’s failure to perform under a loan agreement, to make a payment to the lender and acquire the pledged investment interests. The Company’s obligation is limited to an amount equal to the lesser of the outstanding loan balance or the fair value of the pledged investment interests at the time the guarantee is triggered. As of December 31, 2025, no loans were outstanding subject to the buyback provision. As of December 31, 2025, no defaults or repurchases have occurred under the EIP.

Litigation

In the normal course of business, the Company may enter into contracts that contain a number of representations and warranties, which may provide for general or specific indemnifications. The Company’s exposure under these contracts is not currently known, as any such exposure would be based on future claims, which could be made against the Company. The Company’s management is not currently aware of any such pending claims and based on its experience, the Company believes the risk of loss related to these arrangements to be remote.

From time to time, the Company is a defendant in various lawsuits related to its business. The Company’s management does not believe that the outcome of any current litigation will have a material effect on the Company’s Consolidated Financial Statements.

Off-Balance Sheet Risks

The Company may be exposed to a risk of loss by virtue of certain subsidiaries serving as the general partner of GCM Funds organized as limited partnerships. As general partner of a GCM Fund organized as a limited partnership, the Company’s subsidiaries that serve as the general partner have exposure to risk of loss that is not limited to the amount of its investment in such GCM Fund. The Company cannot predict the amount of loss, if any, which may occur as a result of this exposure; however, historically, the Company has not incurred any significant losses and management believes the likelihood is remote that a material loss will occur.

  1. Related Parties

In regard to the following related party disclosures, the Company’s management cannot be sure that such transactions or arrangements would be the same to the Company if the parties involved were unrelated and such differences could be material.

The Company provides certain employees partnership interest awards which are paid or settled by Holdings, Holdings II and Management LLC. Refer to Note 11 for further details.

The Company has a sublease agreement with Holdings. Because the terms of the sublease are identical to the terms of the original lease, there is no impact to net income in the Consolidated Statements of Income (Loss) or Consolidated Statements of Cash Flows.

The Company incurs certain costs, primarily related to accounting, client reporting, investment-decision making and treasury-related expenditures, for which it receives reimbursement from the GCM Funds in connection with its performance obligations to provide investment management services. The Company also incurs certain costs, primarily related to employee benefits and travel, for which it receives reimbursement from Holdings. Due from related parties in the Consolidated Statements of Financial Condition includes net receivables from GCM Funds of $14.5 million and $12.6 million as of December 31, 2025 and 2024, respectively, and from Holdings of less than $0.1 million as of December 31, 2025 and 2024 for amounts paid on behalf of affiliated entities that are reimbursable to the Company. No net payables to GCM Funds were accrued as of December 31, 2025 and 2024.

Our executive officers, senior professionals, and certain current and former employees and their families invest on a discretionary basis in GCM Funds, and such investments are generally not subject to management fees and performance fees.

Certain employees of the Company have an economic interest in an entity that is the owner and landlord of the building in which the principal headquarters of the Company are located. The Company paid $2.8 million,$2.6 million, and $2.6 million for the years ended December 31, 2025, 2024 and 2023, respectively, related to this lease. This expense is recorded within general, administrative and other in the Consolidated Statements of Income (Loss).

The Company utilizes the services of an insurance broker to procure insurance coverage, including its general commercial package policy, workers’ compensation and professional and management liability coverage for its directors and officers. Certain members of Holdings have an economic interest in, and relatives are employed by, the Company’s insurance broker.

From time to time, certain of the Company’s executive officers utilize a private business aircraft, including an aircraft wholly owned or controlled by members of Holdings. Additionally, the Company arranges for the use of the private business aircraft through a number of charter services, including entities predominantly or wholly owned or controlled by members of Holdings. The Company paid, net of reimbursements, approximately $3.6 million,$2.1 million and$3.4 million for the years ended December 31, 2025, 2024 and 2023, respectively, to utilize aircraft and charter services wholly owned or controlled by members of Holdings, which is recorded within general, administrative and other in the Consolidated Statements of Income (Loss).

In an internal restructuring effective January 1, 2024, GCMH acquired from its general partner, IntermediateCo, the equity interests in GCM, L.L.C. held by IntermediateCo for cash consideration in the amount of approximately $2.0 million. The transaction was completed in accordance with the terms of a transfer agreement. IntermediateCo, a wholly owned subsidiary of GCM Grosvenor Inc., acquired GCM, L.L.C. in connection with the Transaction for nominal consideration and continues to control GCM, L.L.C. indirectly as general partner of GCMH.

During the year ended December 31, 2025, CF Sponsor, Holdings or their permitted transferees exercised the private placement warrants they held on a cashless basis, resulting in the issuance of shares of Class A common stock and no cash proceeds to the Company. Refer to Note 8 for further details on this transaction.

  1. Income Taxes

The income (loss) before income taxes for the years ended December 31, 2025, 2024 and 2023 consist of the following U.S. and foreign components:

Year Ended December 31,
202520242023
United States income$148,316$44,541$(27,130)
Foreign income6,6275,6235,616
Income (loss) before income taxes$154,943$50,164$(21,514)

The provision for income taxes for the years ended December 31, 2025, 2024 and 2023 consist of the following:

Year Ended December 31,
202520242023
Current:
Federal$4,207$637$(282)
State and local(1)2,6753,3283,309
Foreign1,9421,8341,839
Total current provision for income taxes$8,824$5,799$4,866
Deferred:
Federal$1,683$5,945$3,730
State and local(1)2,1711,293(886)
Foreign225523(18)
Total deferred income taxes expense4,0797,7612,826
Total provision for income taxes$12,903$13,560$7,692

(1)New York City made up the majority of the tax effect in this category for each of the years ended December 31, 2025, 2024 and 2023.

A reconciliation of the U.S. statutory income tax rate to the Company’s effective tax rate is as follows:

Year Ended December 31,
202520242023
AmountRateAmountRateAmountRate
Statutory U.S. federal income tax rate$32,53821%$10,53521%$(4,518)21%
State and local income taxes, net of federal income tax effect4,7263%3,3297%2,597(12)%
Foreign tax effect:
Japan
Income tax expense**8322%929(4)%
Withholding tax**7602%278(1)%
Other**(77)—%(63)—%
United Kingdom
Income tax expense****307(1)%
Foreign tax credits****(134)1%
Other foreign jurisdictions1,8401%4481%175(1)%
Effect of cross-border tax laws(23)—%(13)—%(52)—%
Change in valuation allowance(326)—%(1,542)(4)%718(4)%
Nontaxable or nondeductible items:
NCI, less tax expense within NCI(20,859)(14)%(4,719)(9)%8,019(37)%
Change in fair value of warrant liabilities (net of NCI)(1,209)(1)%7911%(68)—%
Tax receivable agreement liability expense(464)—%181—%332(2)%
Other114—%(120)—%(13)—%
Changes in unrecognized tax benefits(551)—%1,0292%0—%
Other adjustments:
Gain/Loss on Warrants(3,207)(2)%2,4455%(220)1%
Provision-to-return adjustments397—%4—%(336)2%
Other(73)—%(323)(1)%(259)1%
Effective income tax rate$12,9038%$13,56027%$7,692(36)%
  • Immaterial for period and included in Other foreign jurisdictions.

For the years ended December 31, 2025, 2024 and 2023, cash tax payments were made in the following jurisdictions:

Year Ended December 31,
2025 · 2024 · 2023
Federal$1,797$349$5
State and local:Year Ended
New York City2,134Year Ended2,3601,632
Illinois*Year Ended(266)*
Wisconsin*Year Ended318*
Other states626Year Ended36946
Foreign:Year Ended
Japan1,290Year Ended9201,056
U.K.463Year Ended513593
Hong Kong*Year Ended316*
Canada*Year Ended*176
Other foreign jurisdictions188Year Ended137(62)
Total income taxes paid, net of refunds$6,498$5,016$3,446
  • Immaterial for period and included in Other states or Other foreign jurisdictions.

Details of the Company’s deferred tax assets and liabilities are as follows:

As of December 31,
20252024
Investment in GCMH$127,384$93,045
Intangibles and other1,7461,111
Total deferred tax assets before valuation allowance129,13094,156
Valuation allowance(72,129)(40,869)
Total deferred tax assets$57,001$53,287
Right-of-use asset$(512)$(612)
Unrealized gains—(1,558)
Other deferred tax liability(580)(430)
Total deferred tax liabilities(1)$(1,092)$(2,600)
Deferred tax assets, net(2)$55,909$50,687

(1) As of December 31, 2025 and 2024, $0.3 million and $2.1 million of deferred tax liabilities, respectively, were offset and presented within deferred tax asset, net in the Consolidated Statements of Financial Condition as these deferred tax assets and liabilities relate to the same jurisdiction.

(2) As of December 31, 2025 and 2024, $0.8 million and $0.5 million of deferred tax liabilities are presented within accrued expenses and other liabilities in the Consolidated Statements of Financial Condition

(In thousands, except share and per share amounts and where otherwise noted

The deferred tax assets and liabilities are presented in our Consolidated Statements of Financial Condition as follows:

As of December 31,
20252024
Deferred tax asset, net$56,711$51,160
Deferred tax liability(1)802473
Total deferred tax asset, net$55,909$50,687

(1) Deferred tax liabilities are presented within accrued expenses and other liabilitiesin the Consolidated Statements of Financial Condition

GCMG’s sole material asset is its investment in GCMH, which is treated as a partnership for U.S. federal income tax purposes and for purposes of certain jurisdictional income taxes. GCMH’s net taxable income and any related tax credits are passed through to its partners and are included in the partners’ tax returns, even though such net taxable income or tax credits may not have actually been distributed. While GCMG consolidates GCMH for financial reporting purposes, GCMG will be taxed on its share of earnings of GCMH not attributed to the noncontrolling interest holders, which will continue to bear their share of income tax on allocable earnings of GCMH. The income tax burden on the earnings taxed to the noncontrolling interest holders is not reported by the Company in its consolidated financial statements under GAAP. As a result, the Company’s effective tax rate differs materially from the statutory rate. The primary factors impacting the effective tax rate are the allocation of income (loss) to noncontrolling interest as well as state and foreign income taxes paid at the partnership level that are included in income tax expenses.

GCMG has recorded a valuation allowance of approximately $72.1 million and $40.9 million as of December 31, 2025 and 2024, respectively, an increase of $31.2 million, which is primarily related to its outside partnership basis of its investment in GCMH for the amount of the deferred tax asset that is not expected to be realized.

The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. As of December 31, 2025, tax years for 2025, 2024, 2023, 2022, and 2021 are subject to examination by the tax authorities. With few exceptions, as of December 31, 2025, the Company is no longer subject to U.S. federal, state, local, or foreign examinations by tax authorities for years before 2021.

For the years ended December 31, 2025, 2024 and 2023, GCMG’s unrecognized tax benefits relating to uncertain tax position, excluding related interest and penalties, consisted of the following:

Year Ended December 31,
202520242023
Unrecognized tax benefits, beginning of period$714$—$—
Gross increases in tax positions in prior periods—714—
Gross decreases in tax positions in prior periods(451)——
Gross increases in tax positions in current period———
Lapse of statute of limitations———
Settlements with taxing authorities———
Unrecognized tax benefits, end of period$263$714$—

If the above tax benefits were recognized, the effective income tax rate would be reduced. GCMG recognized interest and penalties accrued related to unrecognized tax benefits as income tax expense. Related to the unrecognized tax benefits, GCMG has accrued interest of $0.2 million and $0.3 million as of December 31, 2025 and 2024, respectively.

  1. Earnings (Loss) Per Share

The following is a reconciliation of basic and diluted earnings (loss) per share for the years ended December 31, 2025, 2024 and 2023:

Year Ended December 31,
202520242023
Numerator for earnings (loss) per share calculation:
Net income attributable to GCM Grosvenor Inc., basic$45,371$18,695$12,774
Exchange of Partnership units42,241(12,156)(65,812)
Exercise of private warrants(316)——
Exercise of public warrants(5,095)——
Net income (loss) attributable to common stockholders, diluted$82,201$6,539$(53,038)
Denominator for earnings (loss) per share calculation:
Weighted-average shares, basic51,955,62744,741,33643,198,517
Exchange of Partnership units142,588,005144,235,246144,235,246
Exercise of private warrants - incremental shares under the treasury stock method64,644——
Exercise of public warrants - incremental shares under the treasury stock method1,193,123——
Assumed vesting of RSUs - incremental shares under the treasury stock method1,487,1111,613,459—
Weighted-average shares, diluted197,288,510190,590,041187,433,763
Basic EPS
Net income attributable to common stockholders, basic$45,371$18,695$12,774
Weighted-average shares, basic51,955,62744,741,33643,198,517
Net income per share attributable to common stockholders, basic$0.87$0.42$0.30
Diluted EPS
Net income (loss) attributable to common stockholders, diluted$82,201$6,539$(53,038)
Weighted-average shares, diluted197,288,510190,590,041187,433,763
Net income (loss) per share attributable to common stockholders, diluted$0.42$0.03$(0.28)

When applying the if-converted method to calculate the potential dilutive impact of the exchangeable common units of the Partnership, the earnings (loss) per share numerator adjustment reflects the net income attributable to noncontrolling interests in GCMH, as reported, adjusted for the hypothetical incremental provision for income taxes that would have been recorded by the Company if the units had been converted.

Shares of the Company’s Class C common stock do not participate in the earnings or losses of the Company and are therefore not participating securities. As such, a separate presentation of basic and diluted earnings (loss) per share of Class C common stock under the two-class method has not been presented.

The following outstanding potentially dilutive securities were excluded from the calculations of diluted earnings (loss) per share attributable to common stockholders because their impact would have been antidilutive for the periods presented:

Year Ended December 31,
202520242023
Public warrants—16,784,97016,784,970
Private warrants—900,000900,000
Unvested RSUs under the treasury stock method——808,716
  1. Regulatory and Net Capital Requirements

We are required to maintain minimum net capital balances for regulatory purposes for certain of our foreign subsidiaries as well as for our U.S. broker-dealer subsidiary. These net capital requirements are met by retaining cash. The Company's U.S. registered broker-dealer is subject to the SEC’s Uniform Net Capital Rule (“Rule 15c3-1”), which requires the maintenance of minimum net capital and requires that the ratio of aggregate indebtedness to net capital, as defined, shall not exceed 15 to 1. As of December 31, 2025, the Company's U.S. registered broker-dealer had net capital, as defined under Rule 15c3-1, of $0.7 million and excess net capital of $0.7 million. The ratio of aggregate indebtedness to net capital was 0.21 to 1. As of December 31, 2025, all regulated entities and the broker-dealer subsidiary are in compliance with regulatory requirements.

Although the Company's U.S. registered broker-dealer does not claim exemption from the Rule 15c3‐3 of the Securities and Exchange Commission, it does not transact a business in securities with, or for, any person defined as a “customer” pursuant to Rule 17a‐5(c)(4) and does not carry margin accounts, credit balances, or securities for any person defined as a “customer” pursuant to Rule 17a‐5(c)(4).

  1. Segments

The Company conducts its operations through a single reportable segment representing the consolidated entity offering comprehensive alternative investment solutions to institutional and individual investors. The single reportable segment earns substantially all its revenue from management fees and incentive fees.

The chief operating decision maker (“CODM”), who is the Chief Executive Officer, manages the Company on a consolidated basis and utilizes Net income (loss) as presented on the Consolidated Statements of Income (Loss) as the primary financial measure used in assessing the performance of the Company, monitoring budget versus actual results and determining discretionary compensation.

The CODM does not review segment assets at a different asset level or category than the Consolidated Statements of Financial Condition.

The following table presents the Company’s segment operating revenue, significant segment expenses, other income, and segment net income (loss) for the years ended December 31, 2025, 2024 and 2023:

Year Ended December 31,
202520242023
Segment operating revenue$557,565$514,012$444,999
Less:
Cash-based employee compensation and benefits151,213148,547156,153
Equity-based compensation45,59948,15850,667
Partnership interest-based compensation46,18172,068103,934
Carried interest compensation31,37430,45028,505
Cash-based incentive fee related compensation44,51736,45515,628
Other non-cash compensation4485581,157
General, administrative and other(1)104,779104,296100,801
Investment income(16,258)(15,589)(11,640)
Interest expense22,78924,16023,745
Other income(2)(6,283)(1,334)(1,008)
Change in fair value of warrants(21,737)16,079(1,429)
Provision for income taxes12,90313,5607,692
Segment net income (loss)$142,040$36,604$(29,206)
Reconciliation of profit or loss
Adjustments and reconciling items———
Consolidated net income (loss)$142,040$36,604$(29,206)

(1)General, administrative and other consists primarily of professional fees, travel and related expenses, IT operations, communications and information services, occupancy, fund expenses, depreciation and amortization, and other costs associated with our operations.

(2)Other income consists primarily of other non-operating items, including write-off of unamortized debt issuance costs due to prepayments and refinancing of debt and interest income.

  1. Subsequent Event

On February 9, 2026, GCM Grosvenor’s Board of Directors declared a quarterly dividend of $0.12 per share of Class A common stock to record holders as of the close of business on March 2, 2026. The payment date will be March 16, 2026.

In February 2026, the Company completed a prepayment of $65 million on our outstanding 2030 Term Loans.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.